Targeted Oncology - Immunotherapy, Biomarkers, and Cancer …
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.
About Us - Targeted Oncology
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.
Novel Frontline Treatments Add Layer of Complexity in Urothelial …
1 天前 · The past 12 months have seen the FDA approvals of enfortumab vedotin plus pembrolizumab for patients with locally advanced or metastatic urothelial cancer and …
FDA Reviews NDA for Dordaviprone in H3K27M-Mutant Diffuse …
8 小时之前 · The FDA is reviewing a new drug application (NDA) for dordaviprone (ONC201), a potential treatment for patients with recurrent H3K27M-mutant diffuse glioma.; Clinical data …
Updates From COMMANDS at ASH 2024 - targetedonc.com
1 天前 · Thomas W. LeBlanc, MD, MA, discusses how the COMMANDS study, which compared luspatercept to epoetin alfa in erythropoiesis-stimulating agent (ESA)–naive, transfusion …
“Sky Is the Limit” for ADC Possibilities in NSCLC
11 小时之前 · Recent regulatory activities suggest that the understanding of TROP2-directed therapies remains muddled. TROP2-directed therapies, specifically antibody-drug conjugates …
Targeted Therapies in Oncology - Targeted Oncology
Targeted Therapies in Oncology provides evidence-based news and updates on the most current advances in therapeutics, biomarkers, pathways, biomarkers, molecular profiling, and …
Treatment Resources - Targeted Oncology
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.
Latest Conference Articles - Targeted Oncology
2024年11月15日 · A single infusion of the autologous GPRC5D-targeted CAR T-cell therapy BMS-986393 led to high response rates in patients with relapsed/refractory multiple myeloma …
ADCs Change the Game for Cancer Treatment - Targeted Oncology
2024年5月29日 · Loncastuximab Tesirine. The CD19-directed loncastuximab tesirine-lpyl (Zynlonta) gained an FDA orphan drug designation in 2017 7 and was granted accelerated …